2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium – MDA – Continuing Education (CE)
MDA, 2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium, 5/21/2025 7:30:00 AM – 5/22/2025 5:00:00 PM, Myelodysplastic Syndromes (MDS) continue to pose significant challenges in the field of hematologic oncology. Advancing treatment strategies for MDS hinges on a deeper understanding of the biological mechanisms governing hematopoietic stem cell function in both normal and stress conditions. To address this, the upcoming MDS symposium aims to bring together global experts specializing in various aspects of hematopoiesis and MDS. This collaborative effort seeks to facilitate knowledge exchange, foster new insights, and drive forward molecular and therapeutic discoveries in the field of MDS. By convening leaders from around the world, the symposium aims to catalyze progress in understanding and treating this complex blood cancer.
